This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic drugs. It serves as a key chiral building block in the production of compounds targeting neurological and psychiatric disorders, such as antidepressants and antipsychotics. Its unique structure, featuring a difluorophenyl group, enhances the biological activity and selectivity of the final drug molecules. Additionally, it is employed in research settings for studying enzyme interactions and receptor binding mechanisms due to its specific stereochemistry and functional groups.